Switch to
View more

Windlas Biotech Ltd

WINDLAS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹468 cr, stock is ranked 1,293
Moderate RiskStock is 2.00x as volatile as Nifty
214.802.70 (+1.27%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹468 cr, stock is ranked 1,293
Moderate RiskStock is 2.00x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
12.29
PB RatioPB Ratio
2.35
Dividend YieldDiv. Yield
0.48%
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company provides pharmaceutical development services. It provides contract manufacturing services for pharmaceutical industrialists and also focuses on product development and manufacturing capabilities in generic products.

Investor PresentationView older 

Aug 4, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022361.07331.34436.34472.6463.8216.2115.8238.09
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.40%

See detailed holdings

Recent EventsAll events 

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 9, 2022

Windlas Biotech Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Windlas Biotech Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Recording of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 5, 2022

Windlas Biotech Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call | Download

Windlas Biotech Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call | Download

General updates 
Announced OnAug 4, 2022

Windlas Biotech Limited has informed the Exchange about Statement of Deviation for the quarter ended June 30, 2022 | Download

Windlas Biotech Limited has informed the Exchange about Statement of Deviation for the quarter ended June 30, 2022 | Download

See all events